MS and related diseases: a larger share of eye nerve cases
Key Takeaway
New cases of optic neuritis (swelling of the nerve from eye to brain) fell during the pandemic, but more cases involved MS or related diseases in 2021.
What They Found
Researchers counted new cases of optic neuritis (swelling of the nerve from eye to brain) in South Korea from 2017 through 2022. New cases were less common in 2020, 2021, and 2022 than before the pandemic. The researchers accounted for differences in age and sex when comparing these periods. In 2021, about 11% of people with a new case also had MS or one of two related diseases. Before the pandemic, that share was about 6%. The study did not report separate changes for each disease.
Who Should Care and Why
The study included children and adults in South Korea diagnosed with optic neuritis (swelling of the nerve from eye to brain). It did not study only people with MS. It looked at how often new cases occurred across different pandemic periods. It also examined how many people with new cases had MS or related diseases. The findings describe patterns in diagnoses, not the cause of any one person's condition.
Important Considerations
You should know this was a review of past health insurance records covering 7,216 people, not a treatment trial. These records cannot tell you whether vaccination caused optic neuritis (swelling of the nerve from eye to brain). The reported increase grouped MS with two related diseases, so it does not show whether the share with MS alone changed.
AI-generated summary — for informational purposes only, not medical advice
Categories:
Article Topics:
You May Also Like
11/1/2026
Researchers compared blood from people with childhood-onset MS and healthy volunteers. They found DN
Read More
11/1/2026
In 24 people with severe MS, stem cell treatment lowered signs of inflammation and nerve damage for
Read More
11/1/2026
A review of 49 studies finds special brain scans can detect MS-related inflammation, but scan method
Read More
11/1/2026
In a study of 294 pregnancies, MS flare-ups were uncommon after pausing two treatments. Learn what t
Read More
10/9/2026
A mouse study suggests prepared red blood cells may calm MS-like immune attacks. Learn why liver cel
Read More
10/9/2026
See how lab-grown nerve cells move a key protein, why this may matter for nerve health, and why the
Read MoreUnderstanding MS Research
Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Ophthalmology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.